Hualan Biological Engineering
002007.SZ
#2712
Rank
$4.96 B
Marketcap
$2.72
Share price
-1.11%
Change (1 day)
-13.78%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2023 (TTM): $0.29 B

According to Hualan Biological Engineering's latest financial reports the company's current earnings (TTM) are $0.27 B. In 2022 the company made an earning of $0.21 B a decrease over its 2021 earnings that were of $0.26 B.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) $0.29 B39.21%
2022 $0.21 B-19.12%
2021 $0.26 B-17.9%
2020 $0.31 B37.11%
2019 $0.23 B11.71%
2018 $0.20 B50.84%
2017 $0.13 B1.1%
2016 $0.13 B23.49%
2015 $0.11 B8.37%
2014 $0.10 B10.83%
2013 $91.58 M54.56%
2012 $59.25 M-17.03%
2011 $71.41 M-41.34%
2010 $0.12 B6.15%
2009 $0.11 B261.3%
2008 $31.74 M85.75%
2007 $17.08 M49.27%
2006 $11.44 M56.98%
2005 $7.29 M34.28%
2004 $5.43 M